CellSource Co., Ltd.

¥271.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4880Healthcare
Country Japan
PE (Fwd) •••
TSR 7Y CAGR (15.48%)
Div yield 1.85%
ROE —
Biotechnology
Beta (5Y) 0.03
PE TTM 76.75
TSR TTM (46.34%)
Mkt cap ¥5.380B
ROIC 7.83%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥292
7.67%
(29.97%)
Sell 1|6|12|7|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
3.44
3.83
4.02
4.00
23.91%
31.93%
28.10%
28.44%
Revenue¥M
354.5
356.1
355.3
351.5
4.35%
5.23%
1.55%
(0.41%)
Peers (US$34.16M)
Cap (US$)
PE
32.55M
24.18x
Capital
TTM
5Y
10Y
Leveragex
2.808
0.088
0.089
EBIT/Intx
1.374
1.239
0.932
Own earn%
26.36
15.14
22.28
Sh yield%
21.36
28.80
36.87
Owners
Insiders/Inst%
13.50
35.41
Short interest%
5.14
SBC / revenue%
3.49
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
24–30
$1 testx
−0.5
Incr. ROIC%
11